Sodium-Glucose Co-Transporter 2 Inhibitors' Use in Muscular Dystrophy-Related Cardiomyopathy: Data from a Single-Center Experience.

J Clin Med · 2026 · PMC13116835 · PMID 42074900

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

did not reach statistical significancep = 0.063so close (0.05 < p ≤ 0.1)

Dyspnoea on exertion was reported by nine patients (38%) at V1 and by only 2 (11%) at V3, a reduction that, although large, did not reach statistical significance ( p = 0.063).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.